Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced four teams of researchers who will focus on on cancers of the lung and pancreas using the new approach of “interception” of cancers at very early stages.
Stand Up To Cancer has awarded 10 SU2C Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate borders on clinical trials across a variety of cancers, in a program supported by industry.
Barbara McAneny received the Annual Achievement Award of the Association of Community Cancer Centers.
The National Comprehensive Cancer Network said its registration count has grown to more than one million users. By registering on the NCCN website, users are able to view and download all of the NCCN Clinical Practice Guidelines in Oncology free of charge for non-commercial use. According to the latest count, the number of registered users has grown to 1,013,449.
Fox Chase Cancer Center has partnered with Suburban Community Hospital to open the Fox Chase Cancer Center East Norriton Hospital Outpatient Center.
Xiongbin Lu was named the Vera Bradley Foundation Professor of Breast Cancer Innovation at Indiana University School of Medicine. He is also professor of medical and molecular genetics at IU School of Medicine and a member of the Experimental and Developmental Therapeutics research program at the Indiana University Melvin and Bren Simon Cancer Center.
The George Washington University Cancer Center announced a new state-of-the-art mobile mammography van, known as the GW Mammovan.
The Parker Institute for Cancer Immunotherapy said researchers at Dana-Farber Cancer Institute have joined its network. xxx:moreLeadership at both institutions has identified projects that support the Parker Institu
The European Society for Medical Oncology granted the recently established ESMO award for immuno-oncology to Laurence Zitvogel for her internationally recognised achievements.
Salk professor and Howard Hughes Medical Institute investigator Ronald Evans was awarded $2.5 million by Stand Up to Cancer as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.
